Design and Synthesis of USP1 Inhibitors: Synergistic Antitumor Activity with PARP Inhibitors in Triple-Negative Breast Cancer
Abstract
validation for USP1-PARP inhibitor combination therapy in TNBC.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Advanced Breast Cancer Therapies
Cancer Treatment and Pharmacology
Publication details
- Journal / source
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Volume
- 69
- Issue
- 9
- Pages
- 10594–10620
- Publication date
- 29 April 2026
- Language
- EN